Catalio Capital Management
Catalio Capital Management is a venture capital firm founded in 2020 and based in New York, specializing in investments within the biomedical technology sector. The firm manages multiple funds, including the Catalio Access Funds and various special opportunities and credit funds. Catalio employs a diverse investment strategy that encompasses private equity, private credit, and public equity, utilizing a long bias and fundamental analysis approach. With a focus on breakthrough biomedical technologies, Catalio aims to support innovative companies in this rapidly evolving industry. Additionally, the firm is a Registered Investment Adviser, ensuring compliance with regulatory standards in its investment activities.
RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.